Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

1.8K
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fourier transform infrared spectra and machine learning to detect low HER2 expression in breast cancer plasma.

Photodiagnosis and photodynamic therapy·2026
Same author

Preclinical demonstration of the efficacy and mechanisms of antitumor activity of dihydroartemisinin in cholangiocarcinoma xenograft: Induction of autophagy and reprogramming of metabolism.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Indoleamine 2,3-dioxygenase 1 expression predicts cholangiocarcinoma patient survival.

Experimental and molecular pathology·2026
Same author

UHPLC-QTOF-MS/MS-based metabolomic discovery of anticancer compounds in ethanolic extracts of Ficus hispida L. f.

PloS one·2026
Same author

Conserved Phosphoprotein Networks Identify Actionable Adhesion/Wnt and Metallothionein Modules in Cholangiocarcinoma.

Medical sciences (Basel, Switzerland)·2026
Same author

Discovery and clinical significance of 1p36 chromosomal aberrations in differentiating hepatocellular carcinoma from other hepatobiliary cancers.

Human pathology·2026

Related Experiment Video

Updated: Apr 27, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.1K

Increased EphB2 expression predicts cholangiocarcinoma metastasis.

Walaiporn Khansaard1, Anchalee Techasen, Nisana Namwat

  • 1Department of Biochemistry, Liver Fluke and Cholangiocarcinoma Research Center, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand.

Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine
|July 12, 2014
PubMed
Summary

EphB2 receptors and ephrinB1/B2 ligands are upregulated in cholangiocarcinoma (CCA), promoting metastasis. Suppressing EphB2 may offer a therapeutic strategy for CCA by inhibiting cell migration and downstream signaling.

More Related Videos

Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

970
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

43.7K

Related Experiment Videos

Last Updated: Apr 27, 2026

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction
07:44

Endoscopic Ultrasound-Guided Biliary Drainage: Endoscopic Ultrasound-Guided Hepaticogastrostomy in Malignant Biliary Obstruction

Published on: March 25, 2022

6.1K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

970
A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
07:35

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer

Published on: December 26, 2016

43.7K

Area of Science:

  • Molecular Biology
  • Oncology

Background:

  • Eph receptors and their ligands are cell surface receptors involved in cell signaling.
  • Recent studies suggest a role for Eph receptors in human cholangiocarcinoma (CCA).

Purpose of the Study:

  • To investigate the expression and role of Eph receptors and their ligands in human CCA.
  • To explore the correlation between Eph receptor/ligand expression and CCA metastasis.
  • To evaluate the therapeutic potential of targeting EphB2 in CCA.

Main Methods:

  • Immunohistochemical staining of 50 human CCA tissues to assess EphB2, EphB4, ephrinB1, and ephrinB2 expression.
  • Correlation analysis between protein expression levels and clinicopathological features, including metastatic status.
  • siRNA-mediated suppression of EphB2 in CCA cells to evaluate effects on cell migration and downstream signaling pathways (FAK, paxillin).

Main Results:

  • EphB2, EphB4, ephrinB1, and ephrinB2 were 100% positive in CCA tissues.
  • High expression of EphB2 and co-expression of EphB2/ephrinB1 or EphB2/ephrinB2 significantly correlated with metastasis.
  • High co-expression of EphB4/MVD and ephrinB1/MVD also correlated with metastasis.
  • EphB2 suppression reduced CCA cell migration and decreased FAK/paxillin phosphorylation.

Conclusions:

  • Upregulation of EphB2 receptors and ephrinB1/B2 ligands contributes to CCA metastasis.
  • Targeting EphB2 and its downstream signaling pathways presents a potential therapeutic strategy for human CCA.